X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (150) 150
life sciences & biomedicine (147) 147
animals (107) 107
protein-serine-threonine kinases - metabolism (85) 85
humans (78) 78
protein-serine-threonine kinases - genetics (68) 68
immediate-early proteins - metabolism (56) 56
mice (48) 48
physiology (48) 48
immediate-early proteins - genetics (46) 46
biochemistry & molecular biology (40) 40
cell biology (38) 38
phosphorylation (37) 37
male (33) 33
cell line (31) 31
immediate-early proteins (30) 30
rats (30) 30
female (24) 24
urogenital system (23) 23
nuclear proteins (22) 22
cells, cultured (20) 20
gene expression (20) 20
urology & nephrology (19) 19
corticosteroids (18) 18
epithelial sodium channels (18) 18
original paper (18) 18
signal transduction (18) 18
sodium - metabolism (18) 18
kinases (17) 17
rna, messenger - metabolism (17) 17
serum (16) 16
aldosterone (15) 15
protein-serine-threonine kinases - physiology (15) 15
proteins (14) 14
rna, messenger - genetics (14) 14
amino acid sequence (13) 13
mice, knockout (13) 13
nedd4 ubiquitin protein ligases (13) 13
pharmacology & pharmacy (13) 13
protein kinases (13) 13
protein-serine-threonine kinases - biosynthesis (13) 13
sodium channels - metabolism (13) 13
biophysics (12) 12
epithelial sodium channel (12) 12
oncology (12) 12
phosphoinositide 3-kinase (12) 12
protein-serine-threonine kinases - antagonists & inhibitors (12) 12
transfection (12) 12
apoptosis (11) 11
immediate-early proteins - physiology (11) 11
molecular sequence data (11) 11
research article (11) 11
signal transduction - drug effects (11) 11
aldosterone - pharmacology (10) 10
biochemistry (10) 10
cardiovascular system & cardiology (10) 10
dexamethasone - pharmacology (10) 10
genes (10) 10
glucocorticoids (10) 10
phosphatidylinositol 3-kinases - metabolism (10) 10
pi3k, phosphoinositide 3-kinase (10) 10
rats, sprague-dawley (10) 10
ubiquitin-protein ligases - metabolism (10) 10
xenopus laevis (10) 10
akt (9) 9
cancer (9) 9
mutation (9) 9
neurosciences (9) 9
pkb, protein kinase b (9) 9
protein kinase b (9) 9
protein kinase inhibitors - pharmacology (9) 9
rats, wistar (9) 9
reverse transcriptase polymerase chain reaction (9) 9
serum and glucocorticoid inducible kinase (9) 9
steroids (9) 9
time factors (9) 9
cell line, tumor (8) 8
cell membrane - metabolism (8) 8
endosomal sorting complexes required for transport (8) 8
enzyme inhibitors - pharmacology (8) 8
epithelial cells - metabolism (8) 8
gene expression regulation (8) 8
glucocorticoids - pharmacology (8) 8
glucose (8) 8
immediate-early proteins - biosynthesis (8) 8
mapk, mitogen-activated protein kinase (8) 8
medicine & public health (8) 8
neurosciences & neurology (8) 8
peripheral vascular disease (8) 8
protein binding (8) 8
pyrimidines - pharmacology (8) 8
serum and glucocorticoid-inducible kinase (8) 8
sgk1 (8) 8
sodium channels - genetics (8) 8
transcription factors - metabolism (8) 8
endocrinology & metabolism (7) 7
enzyme activation (7) 7
epithelial sodium channels - metabolism (7) 7
erk, extracellular-signal-regulated kinase (7) 7
gene expression regulation - drug effects (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 0264-6021, 07/2009, Volume 421, Issue 1, pp. 29 - 42
...) and SGK (serum and glucocorticoid protein kinase). mTORCI (mTOR complex-1) phosphorylates the hydrophobic motif of S6K, whereas mTORC2 phosphorylates the hydrophobic motif of Akt and SGK... 
Phosphoinositide 3-kinase (PI3K) | Akt/protein kinase B (PKB) | Serum and glucocorticoid protein kinase (SGK) | P70 ribosomal S6 kinase (S6K) | Kinase inhibitor | Cancer | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Line | Humans | Multiprotein Complexes | Morpholines - pharmacology | Transcription Factors - antagonists & inhibitors | Gene Expression Profiling | G1 Phase - drug effects | Pyrimidines - pharmacology | Morpholines - chemistry | Pyrimidines - chemistry | Mechanistic Target of Rapamycin Complex 1 | Gene Expression Regulation - drug effects | Proteins | Transcription Factors - metabolism | Animals | Fibroblasts - drug effects | Cell Proliferation - drug effects | Mice | TOR Serine-Threonine Kinases | Fibroblasts - metabolism | Index Medicus | PI3K, phosphoinositide 3-kinase | PDK, 3-phosphoinositide-dependent protein kinase | AMPK, AMP-activated protein kinase | mTORC, mTOR complex | DTT, dithiothreitol | phosphoinositide 3-kinase (PI3K) | p70 ribosomal S6 kinase (S6K) | SPHK, sphingosine kinase | ERK, extracellular-signal-regulated kinase | RSK, ribosomal S6 kinase | PH domain, pleckstrin homology domain | protein kinase B (PKB) | protein kinase G | NDRG1, N-Myc downstream-regulated gene-1 | IGF, insulin-like growth factor | mTOR, mammalian target of rapamycin | GST, glutathione transferase | SGK, serum and glucocorticoid protein kinase | PKC, protein kinase C | S6K, p70 ribosomal S6 kinase | eIF4E, eukaryotic initiation factor 4E | 4E-BP1, eIF4E-binding protein 1 | protein kinase C family | Akt | PRAS40, proline-rich Akt substrate of 40 kDa | HEK-293 cell, human embryonic kidney 293 cell | kinase inhibitor | MEF, mouse embryonic fibroblast | AGC family, protein kinase A | cancer | serum and glucocorticoid protein kinase (SGK) | MAPK, mitogen-activated protein kinase
Journal Article
Acta pharmaceutica Sinica. B, ISSN 2211-3835, 09/2018, Volume 8, Issue 5, pp. 767 - 771
The serum and glucocorticoid inducible protein kinase (SGK) family members share similar structure, substrate specificity and function with AKT and signal downstream of the phosphatidylinositol 3-kinase (PI3K) signalling pathway... 
PI3K | Kinase | SGK | AKT | Inhibitor | Signalling | Cancer | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Development and progression | Care and treatment | Cellular signal transduction | Research | Protein kinases | PDK1, phosphoinositide-dependent kinase-1 | mTORC2, mammalian target of rapamycin complex 2 | SGK, serum and glucocorticoid inducible protein kinase | ER, estrogen receptor | PH, pleckstrin homology | PI3K, phosphatidylinositol 3-kinase | PX, Phox
Journal Article
Biochemical journal, ISSN 0264-6021, 06/2013, Volume 452, Issue 3, pp. e11 - e13
... (serum- and glucocorticoid-regulated kinase 1). The study could help to profile tumours for sensitivity to Akt inhibitors and once more highlights the therapeutic complexity of cancer and the importance of exploring combination therapies in the clinic. 
Resistance | Serum- and glucocorticoid-regulated kinase SGK | Protein kinase B PKB | Therapy | Protein kinase | Akt | Signalling | AGC kinase | Cancer | Protein-Serine-Threonine Kinases - biosynthesis | Animals | Protein Kinase Inhibitors - therapeutic use | Humans | Immediate-Early Proteins - biosynthesis | Female | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Breast Neoplasms - metabolism | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Biochemical journal, ISSN 1470-8728, 12/2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Index Medicus | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | drug discovery | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | inhibitor specificity | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | anti-cancer drugs | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | protein kinase | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | kinase profiling | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
Biochemical journal, ISSN 1470-8728, 09/2007, Volume 407, Issue 2, pp. 231 - 241
...) were differentially phosphorylated in response to IGF-1, EGF, PMA and AICAR. The binding of 14-3-3 proteins to HA–AS160... 
14-3-3 | Akt/protein kinase B (PKB) | GTPase-activating protein (GAP) | p90 ribosomal S6 kinase (RSK) | Akt substrate of 160 kDa (AS160) | Serum- and glucocorticoid-induced protein kinase (SGK) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Line | Insulin-Like Growth Factor I - pharmacology | Phosphorylation | Humans | GTPase-Activating Proteins - metabolism | Insulin | Amino Acids | Aminoimidazole Carboxamide - pharmacology | Hypoglycemic Agents - pharmacology | 14-3-3 Proteins - metabolism | Ribonucleotides - pharmacology | Aminoimidazole Carboxamide - analogs & derivatives | Protein Binding | Epidermal Growth Factor - pharmacology | Binding Sites | Index Medicus | ACC, acetyl-CoA carboxylase | AGC kinase, protein kinase A | AICAR, 5-amino-4-imidazolecarboxamide1-β-D-ribofuranoside | PI3K, phosphoinositide 3-kinase | EGF, epidermal growth factor | TOS motif, mTOR signalling motif | PAS, phospho-Akt substrate | pSer, phosphorylated serine | TSC, tuberous sclerosis complex | AS160, Akt substrate of 160 kDa | PKB, protein kinase B (also known as Akt) | AMPK, AMP-activated protein kinase | RSK, p90 ribosomal S6 kinase | DSP, dithiobis(succinimidyl propionate) | protein kinase C-family | ERK, extracellular-signal-regulated kinase | PDK1, phosphoinositide-dependent kinase 1 | protein kinase B (PKB) | IGF-1, insulin-like growth factor-1 | Akt substrate of 160 kDa (AS160) | GLUT4, glucose transporter 4 | protein kinase G | mTOR, mammalian target of rapamycin | TORC1, mTOR–raptor (regulatory associated protien of mTOR) complex | 4E-BP1, eukaryotic initiation factor 4E-binding protein 1 | GST, glutathione S-transferase | PKC, protein kinase C | PP2A, protein phosphatase 2A | Akt | SGK, serum- and glucocorticoid-induced protein kinase | HA, haemagglutinin | GSV, GLUT4 storage vesicle | p70S6K, p70 S6 kinase | PTB, phosphotyrosine binding domain | pThr, phosphorylated threonine | GAP, GTPase-activating protein | HEK-293, human embryonic kidney-293 | IRAP, insulin-responsive aminopeptidase | Rheb, Ras enriched in brain | serum- and glucocorticoid-induced protein kinase (SGK) | MAPK, mitogen-activated protein kinase
Journal Article
Journal Article